Relmada Therapeutics
RLMD
RLMD
113 hedge funds and large institutions have $468M invested in Relmada Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 113 → 113 (0)
25% less capital invested
Capital invested by funds: $623M → $468M (-$155M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
113
Holding in Top 10
2
Calls
$29.1M
Puts
$25.2M
Top Buyers
| 1 | +$7.6M | |
| 2 | +$7.56M | |
| 3 | +$4.53M | |
| 4 |
BlackRock
New York
|
+$3.8M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.33M |
Top Sellers
| 1 | -$6.97M | |
| 2 | -$3.73M | |
| 3 | -$3.38M | |
| 4 |
Millennium Management
New York
|
-$3.06M |
| 5 |
CAC
Cowen and Company
New York
|
-$1.85M |